Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exendin peptides.

J Eng1

  • 1Solomon A. Berson Research Laboratory, Veterans Affairs Medical Center, Bronx, NY 10468.

The Mount Sinai Journal of Medicine, New York
|March 1, 1992
PubMed
Summary
This summary is machine-generated.

Exendin-3 and exendin-4, peptides from Gila monster venom, exhibit distinct biological activities. Their interaction with a specific exendin receptor suggests the existence of an endogenous mammalian analog.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The photochemistry of Rydberg-excited cyclobutanone: Photoinduced processes and ground state dynamics.

The Journal of chemical physics·2024
Same author

COVID-19 in patients with lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Understanding the potential for efficient triplet harvesting with hot excitons.

Faraday discussions·2019
Same author

Excited State Intramolecular Proton Transfer Dynamics for Triplet Harvesting in Organic Molecules.

The journal of physical chemistry. A·2019
Same author

The intersystem crossing of a cyclic (alkyl)(amino) carbene gold (i) complex.

The Journal of chemical physics·2018
Same author

CABG morbidity and the internal mammary artery.

The National medical journal of India·2018
Same journal

Farewell message from Penny A. Asbell, MD, FACS, MBA, Editor-in-Chief of the Mount Sinai Journal of Medicine.

The Mount Sinai journal of medicine, New York·2012
Same journal

Minority undergraduate programs intended to increase participation in biomedical careers.

The Mount Sinai journal of medicine, New York·2012
Same journal

Future of electronic health records: implications for decision support.

The Mount Sinai journal of medicine, New York·2012
Same journal

AA amyloidosis: Mount Sinai experience, 1997-2012.

The Mount Sinai journal of medicine, New York·2012
Same journal

Amyloid neuropathies.

The Mount Sinai journal of medicine, New York·2012
Same journal

Should your family history of coronary heart disease scare you?

The Mount Sinai journal of medicine, New York·2012
See all related articles

Area of Science:

  • Biochemistry
  • Endocrinology
  • Peptide Hormone Research

Background:

  • Exendin-3 and exendin-4 are 39-amino acid peptides isolated from Gila monster venom.
  • Both peptides are structurally related to the glucagon superfamily of hormones.
  • They share an amino-terminal histidine and a carboxyl-terminal serine amide.

Purpose of the Study:

  • To investigate the distinct biological activities of exendin-3 and exendin-4.
  • To identify the receptors involved in their action on pancreatic acinar cells.
  • To explore the potential existence of endogenous mammalian analogs.

Main Methods:

  • Isolation of exendin peptides using a chemical assay for N-terminal histidine.
  • Testing peptide activity in a dispersed pancreatic acinar cell assay measuring amylase release and cAMP levels.

Related Experiment Videos

  • Utilizing exendin(9-39) amide as a specific inhibitor to define receptor interactions.

    • Main Results:

    • Exendin-3 stimulates amylase release and causes a biphasic increase in cAMP.
    • Exendin-4 does not stimulate amylase release but causes a monophasic cAMP increase, despite minor sequence differences.
    • Exendin-3 interacts with VIP receptors, while exendin-4 does not.
    • Both peptides bind to a putative exendin receptor on pancreatic acinar cells, inhibited by exendin(9-39) amide.

    Conclusions:

    • Differences in biological activity are attributed to distinct receptor interactions.
    • The presence of a specific exendin receptor suggests the existence of an endogenous mammalian analog.
    • Further research is needed to functionally define the exendin receptor and its endogenous ligand.